Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

May 31, 2006

Conditions

Leishmaniasis, Mucocutaneous

Interventions

BIOLOGICAL

Leish-111f + MPL-SE vaccine

Trial Locations (2)

Universidad Peruana Cayetano Heredia, Lima

Clínica de Leishmaniasis, Hospital Nacional Sur Este EsSalud, Cusco

All Listed Sponsors

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Access to Advanced Health Institute (AAHI)

OTHER

NCT00111514 - Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis | Biotech Hunter | Biotech Hunter